World Preclinical Congress Europe

 , 21 December 2017 | Past event

www.worldpreclinicaleurope.com/3D-Cellular-Models/

Cyprio’s HepatoPearls made another appearance in the “3D cellular models; taking screening into a new dimension” session. While the HepatoPearls were being presented to the audience, Cyprio also presented the results of a collaborative project with Sanofi for high throughput drug-drug interaction screenings.

Our very own CEO, Noushin Dianat, was interviewed during the conference:
www.worldpreclinicaleurope.com/interviews/

Aucun Commentaire »

ALTERTOX academy hands-on training

 , 20 December 2017 | Past event

ALTERTOX academy (ex-CAAT academy) hands-on training: Updates on the Hepatotoxicity AOP Landscape and on the ADME Field Edition 2

www.caat-academy.org

Cyprio’s model, HepatoPearl, was introduced and presented to attendees. Participants of the workshop were given the opportunity to work with this innovative liver 3D cellular model while the Cyprio team explained interesting features about this novel product. This was also the very first time researchers were given the opportunity to work with the HepatoPearls.

Aucun Commentaire »

World Preclinical Congress (WPC)

 , 16 December 2017 | Past event

Cyprio’s CEO, Noushin Dianat, presented how our innovative technology has redefined the limits of 3D Cell Culture in the “3D cellular models” session at World Preclinical Congress.

www.worldpreclinicalcongress.com/wpc/17

Aucun Commentaire »